Steven P. Duddy

Corinth MedTech, Inc. engages in the development of bipolar transurethral and transcervical resection system. Its product includes a compact controller with a single-use fluid control system which is intended for endoscopically controlled tissue removal for male patients diagnosed with benign prostatic hyperplasia, and female patients diagnosed with abnormal uterine bleeding. The company was founded in 2014 and is headquartered in Cupertino, CA.